A profile about the people, projects and experiences behind their work. Discover their career, contributions and connections.
Backed byDetails being loaded
Cosigned byDetails being loaded
Team on CosignDetails being loaded
Team
Team
5
Profile nameProfile nameProfile name
Team
5
Profile nameProfile nameProfile name
Cosigns Received
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Loading organization
Organization name
A profile about the people, projects and experiences behind their work. Discover their career, contributions and connections.
Backed byDetails being loaded
Cosigned byDetails being loaded
Team on CosignDetails being loaded
Team
Team
5
Profile nameProfile nameProfile name
Team
5
Profile nameProfile nameProfile name
Cosigns Received
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Loading organization
Organization name
A profile about the people, projects and experiences behind their work. Discover their career, contributions and connections.
Backed byDetails being loaded
Cosigned byDetails being loaded
Team on CosignDetails being loaded
Team
Team
5
Profile nameProfile nameProfile name
Team
5
Profile nameProfile nameProfile name
Cosigns Received
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Simcha Therapeutics
Simcha Therapeutics is a clinical-stage immunobiology company pioneering the development of first-in-class engineered cytokine therapeutics with transformational promise for patients. The company is built on a foundation of scientific rigor to overcome biological challenges in clinically translatable pathways, exemplified by the first decoy-resistant interleukin-18 (IL-18). By unlocking the potential of IL-18, Simcha is developing its lead program (ST-067) as monotherapy and in combination with potentially several other anticancer agents. ST-067 is currently being studied in a Phase 1/2 clinical trial, in patients with solid tumors and who have progressed on other immunotherapeutic agents. Beyond IL-18, the company’s underlying approach to immune-biology and cytokine engineering has broader potential to support disease-modifying therapeutic options for a range of significant diseases.
Backed by
Loading investors
Founders
Loading founders
Cosigned by
Loading cosigns
Featured roles
Loading featured roles
Team
Loading company relationships
Team
5
Profile nameProfile nameProfile name
Team
5
Profile nameProfile nameProfile name
Loading company cosigns
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.